FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to ophthalmology, and can be used for treatment of "dry" form of age-related macular degeneration. For this purpose at preliminary stage, magnetic implant in form of flat rectangular plate is implanted intrasclerally in projection of macular area. 2 weeks after that, mesenchymal stem cells (MSC) of patient's own bone marrow, labelled with magnetic microparticles, are introduced to patient intravenously during 30-40 minutes. 2 hours before MSC introduction macular area of retina is irradiated by low-intensive laser irradiation with wavelength 632-633 nm, voltage 10 mW, diameter of laser irradiation spot is 4 mm, total time of irradiation is 5 minutes.
EFFECT: invention ensures targeted delivery of MSC to pathological nidus and retaining said cells for the time, required for efficient improvement of microcirculation and trophism of tissues, which contributes to steady stabilisation of visual functions.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING "DRY" FORM OF AGE-SPECIFIC MACULAR DEGENERATION | 2011 |
|
RU2470619C1 |
METHOD OF TREATING "DRY" FORM OF AGE-RELATED MACULAR DEGENERATION | 2012 |
|
RU2485922C1 |
METHOD TO TREAT "DRY" FORM OF AGE MACULAR DEGENERATION | 2007 |
|
RU2333737C1 |
THREE-COMPONENT COMPLEX FOR CELL THERAPY IN OPHTHALMOLOGY | 2012 |
|
RU2495650C1 |
METHOD OF TREATING "DRY" FORM OF AGE MACULAR DEGENERATION | 2008 |
|
RU2375016C1 |
METHOD OF INCREASING EFFECIENCY OF PHOTODYNAMIC THERAPY OF CHOROIDAL NEOVASCULARISATION | 2008 |
|
RU2375023C1 |
METHOD OF TREATING OPTIC NERVE ATROPHY OF VARIOUS ETIOLOGY | 2008 |
|
RU2375021C1 |
METHOD OF SURGICAL TREATMENT OF PROGRESSING AND COMPLICATED MYOPIA | 2012 |
|
RU2494711C1 |
METHOD OF TREATING OPTIC NERVE ATROPHY OF DIFFERENT ETIOLOGY | 2011 |
|
RU2482823C2 |
METHOD OF TREATING OPTIC NERVE ATROPHY OF VARIOUS ETIOLOGY | 2008 |
|
RU2375022C1 |
Authors
Dates
2013-01-10—Published
2011-07-26—Filed